University of California

Other

Grt, Inc.

University of Illinois

Mobil Oil Corporation

Oregon State University

University of Oregon

Mitsubishi Chemical Corporation

Galen D Stucky

Jeffrey H Sherman

Peidong Yang

Ivan Marc Lorkovic

Bradley F Chmelka

Peter C Ford

David J Pine

Sarah Elyse Baker

James H Morrissey

Philip Grosso

Stephanie A Smith

April Sawvel

Gary Bernard Braun

Anna May-Masnou

Damien Kudela

Eric W McFarland

Xiao Ping Zhou

Michael J Weiss

George M Whitesides

Tao Deng

Glenn H Fredrickson

Patrick Schmidt-Winkel

Daniel E Morse

Qisheng Huo

Dieter J Schaefer

Leroy E Laverman

Shouli Sun

David Margolese

Wayne Lukens, Jr

Pingyun Feng

Jianglin Feng

Dongyaun Zhao

Dongyuan Zhao

Nick Melosh

James C Vartuli

David H Olson

Paul K Hansma

Timothy J Deming

Michael Wong

Shannon W Boettcher

Xiulei Ji

Ken Tasaki

Michael Francis Doherty

Qihui Shi

Jennifer Cha

Brian Evanko

John H Harreld

Xingfeng Wang

Todd A Ostomel

Craig Jon Hawker

Jeffrey S Beck

Fred Wudl

Guenter H Kuehl

Nicholas A Melosh

Peter K Stoimenov

Jeffrey A Gerbec

John L Schlenker

Hengbin Wang

Alexander Mikhailovsky

Johannes H Kindt

Jeff S Sakamoto

Ashley W Breed

Arunkumar Venkatesan

Young-Si Jun

Bruno Jousselme

Henrik Birkedal

Michael H Bartl

Jan L Sumerel

Wenbin Hong

Gernot Wirnsberger

Brian J Scott

Howard C Huang

Gurkan Atinc Yilmaz

Aysen Yilmaz

Katsuhiko Shimizu

Yan Zhou

Timothy D Deming

Seung Joon Yoo

Nicholas Parker

David Vonlanthen

Ashley W Rreed

Jason Lipton

David Auston

Sang-Eun Chun

Anzar Khan

David Xiulei Ji

Bao Wang

Nathan L Mitchell

Raghu Subash Chandrabose

Patricia A Holden

Maria Noy

Ivan M Lorkovic

Xiao P Zhou

A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting.

Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

Electrolytes for use in electric double-layer capacitors (EDLCs; often referred as supercapacitors or ultracapacitors) are disclosed. In one example, the electrolyte comprises viologen in both the anolyte and the catholyte (with bromide). In another example, the electrolyte comprises viologen (in the anolyte) and tetraalkylammonium with bromide (in the catholyte), wherein the tetraalkylammonium is used to achieve solid complexation of bromine in the activated carbon of the cathode. In a third example, a zinc bromine/tetraalkylammonium supercapacitor/battery hybrid is disclosed. Also disclosed is a corrosion resistant bipolar pouch cell that can be used with the electrolyte embodiments described herein.

Stable bromine charge storage in porous carbon electrodes using tetraalkylammonium bromides for reversible solid complexation

Graphitic carbon nitride materials are shown to be useful in Lithium-Sulfur electrochemical cells. Batteries that include this material exhibit increased electrode kinetics of the lithium-sulfur electrochemical couple, phenomena that improve the specific capacity, usable lifetime and other desirable characteristics of these batteries. Lithium-sulfur batteries that incorporate these materials can be used to overcome a number of limitations in this technology.

Pnictide containing catalysts for electrochemical conversion reactions and methods of use

An electrical double layer capacitor (EDLC) energy storage device is provided that includes at least two electrodes and a redox-enhanced electrolyte including two redox couples such that there is a different one of the redox couples for each of the electrodes. When charged, the charge is stored in Faradaic reactions with the at least two redox couples in the electrolyte and in a double-layer capacitance of a porous carbon material that comprises at least one of the electrodes, and a self-discharge of the energy storage device is mitigated by at least one of electrostatic attraction, adsorption, physisorption, and chemisorption of a redox couple onto the porous carbon material.

Energy storage device including a redox-enhanced electrolyte

The invention provides a homogeneous composition comprising a hemostatically effective amount of a charged oxide, wherein the composition has an isoelectric point, as measured in calcium chloride, below 7.3 or above 7.4. Typically, the charged oxide is selected from the group consisting of silaceous oxides, titanium oxides, aluminum oxides, calcium oxides, zinc oxides, nickel oxides and iron oxides. In some embodiments, the composition further comprises a second oxide selected from the group consisting of calcium oxide, sodium oxide, magnesium oxide, zinc oxide, phosphorus oxide and alumina. In a typical embodiment of the invention, the charged oxide is silaceous oxide, the second oxide comprises calcium oxide and the ratio, by molar ratio, of silaceous oxide to calcium oxide is 0.25 to 15. Optionally, the composition further comprises phosphorous oxide. Also described are methods of making and using such compositions.

Oxides for wound healing and body repair

Hemostatic compositions comprising a wet layered clay (e.g., wet kaolin) and, optionally, a zeolite, as well as devices and methods of use to promote blood clotting, are provided.

Hemostatic compositions and methods of use

An electrical double layer capacitor (EDLC) energy storage device is provided that includes an electrolyte having an anionic catholyte and a cationic anolyte, a positively charged electrode, and a negative charged electrode, where negatively charged oxidized species in the anionic catholyte are electrostatically attracted to the positively charged electrode, where positively charged reduced species in the cationic anolyte are electrostatically attracted to the negatively charged electrode, where self-discharge of the EDLC energy storage device is prevented.

High energy capacitors boosted by both catholyte and anolyte

The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.

Mesocellular oxide foams as hemostatic compositions and methods of use

Improvements in previously disclosed methods of and apparatuses for converting alkanes, alkenes, and aromatics to olefins, alcohols, ethers, and aldehydes includes: safety improvements, use of alternative feedstocks, process simplification, improvements to the halogenation step, improvements to the reproportionation step, improvements to the solid oxide reaction, improvements to solid oxide regeneration, improvements in separations, maintenance, start-up, shut-down, and materials of construction.

Hydrocarbon conversion process improvements

Growing community of inventors

Santa Barbara, CA, United States of America

Galen D Stucky